β-Amyloid-mediated vasoactivity and vascular endothelial damage
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Deposits of beta-amyloid are apparent in ageing and Alzheimer's disease, but the role of this peptide in neurodegeneration is unclear. The free-radical theory of ageing may also account for Alzheimer-type degeneration and consequently links between free-radical generation and beta-amyloid have been sought. We demonstrate here that beta-amyloid interacts with endothelial cells on blood vessels to produce and excess of superoxide radicals, with attendant alterations in endothelial structure and function. The superoxide radical can scavenge endothelium-derived relaxing factor and produce potent oxidizing agents, which can cause lipid peroxidation and other degenerative changes. The alterations in vascular tone and endothelial damage are prevented by the oxygen-radical-scavenging enzyme superoxide dismutase. These observations suggest a normal vasoactive role for beta-amyloid as well as a mechanism by which beta-amyloid may play a role in vascular abnormalities and neurodegeneration mediated by free radicals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
In the citing paper
“As shown by pharmacological studies, these high concentrations of A b may impair local BBB integrity (58-59), which in turn may contaminate brain ISF with blood and/or plasma that possesses A b -degrading activity (48)”
From Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier (2000) · cites this paper as [59]
In the citing paper
“Aβ4 constrict isolated cerebral and systemic blood vessels (Niwa et al., 2001; Paris et al., 2003; Thomas et al., 1996)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Thomas et al., 1996
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH.
Kukreja, R. C., Kontos, H. A., Hess, M. L., & Ellis, E. F. (1986) · Circulation Research · doi:10.1161/01.res.59.6.612 · Cited by 487
Bu�e, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., & Fillit, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294173 · Cited by 334
Scholz, W. (1938) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02890989 · Cited by 180
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
Untangling the pathophysio-chemistry of β-amyloid
Mattson, M. P. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1195-926 · Cited by 41
Research works printed but not linked: 2
- Davignon, J., Gregg, R. & Sing, C. Atherosclerosis 8, 1–21 (1988).
- Tomimoto, H., Nakimura, S., Wakita, H., Kimura, J. & Akiguchi, I. J. Cereb. Blood Flow Metab. 14, 563–573 (1994).
Cited by
Items 201–300 of 710
Cardiac Disorders as Risk Factors for Alzheimer's Disease
de Toledo Ferraz Alves, T. C., Ferreira, L. K., Wajngarten, M., & Busatto, G. F. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091561 · Cited by 102
“Pathophysiological mechanisms suggested to underlie the association between Aβ and vascular disease include endothelial damage [136,137], vasoactive effects [137], raised blood pressure [138], disruption of cerebrovascular autoregulation [139] and vascular amyloid deposition [140].”
BackgroundPossible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis
Hölscher, C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0193 · Cited by 102
Cerebral autoregulation in Alzheimer's disease
Claassen, J. A. H. R., & Zhang, R. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.69 · Cited by 117
“These observations confirmed the earlier work that had demonstrated that Ab was ‘vasotoxic’ (Thomas et al, 1996).”
BackgroundResultA healthy body, a healthy mind: long-term impact of diet on mood and cognitive function
Rogers, P. J. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200061 · Cited by 102
“For example, biochemical and physiological studies implicate oxidative damage to the central nervous system microvasculature in the aetiology of neurodegenerative diseases, including Alzheimer’s disease (Richardson, 1993; Thomas et al. 1996), and oxidative modification of LDL is thought to be a critical component of t…”
BackgroundThe amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 97
Endothelin-Converting Enzyme-2 Is Increased in Alzheimer’s Disease and Up-Regulated by Aβ
Palmer, J. C., Baig, S., Kehoe, P. G., & Love, S. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081054 · Cited by 112
Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques
Kumar‐Singh, S. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00380.x · Cited by 94
“Some of the other consequences of CAA, such as ischaemia or perivascular inflammation (Cadavid et al. 2000; Eng et al. 2004; Thomas et al. 1996) might in turn also cause progressive dementia.”
BackgroundDo NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P., & Breitner, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 108
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 112
“Ex vivo, Ab40 causes endothelium-dependent vasoconstriction in normal blood vessels (Thomas et al., 1996; Townsend et al., 2002), and intrathecal injection of Ab40 into wild-type and APP transgenic mice impairs the responses to several endotheliumdependent vasodilators (Niwa et al., 2000a).”
BackgroundLinks Between the Pathology of Alzheimer's Disease and Vascular Dementia
Sadowski, M., Pankiewicz, J. E., Scholtzova, H., Li, Y., Quartermain, D., Duff, K., & Wısnıewskı, T. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023612.66691.e6 · Cited by 115
Animal models of cerebral β-amyloid angiopathy
Walker, L. C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00017-9 · Cited by 110
The diabetic brain and cognition
Riederer, P., Korczyn, A. D., Ali, S. S., Bajenaru, O. A., Choi, M. S., Chopp, M., Dobrota, V. Đ., Grünblatt, E., Jellinger, K. A., Kamal, M. A., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1763-2 · Cited by 106
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
Kim, A. Y., Jerdi, S. A., MacDonald, R., & Triggle, C. R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399121 · Cited by 116
The Role of Neurovascular System in Neurodegenerative Diseases
Ahmad, A., Patel, V., Xiao, J., & Khan, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02023-z · Cited by 105
Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activation
Bruce-Keller, A. J., Gupta, S., Knight, A. G., Beckett, T. L., McMullen, J. M., Davis, P. R., Murphy, M. P., Van Eldik, L. J., St Clair, D., & Keller, J. N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.012 · Cited by 96
“For example, early studies revealed the ability of Aβ to activate NOX and increase superoxide production (Meda et al., 1995), (Bruce et al., 1996), (Thomas et al., 1996), (Bianca et al., 1999), (Jana and Pahan, 2004), (Niikura et al., 2004), suggesting that NOX may be involved in Aβ-induced…”
Microglial Contribution to Oxidative Stress in Alzheimer's Disease
COLTON, C. A., CHERNYSHEV, O. N., GILBERT, D. L., & VITEK, M. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06195.x · Cited by 95
Mechanisms of Soluble β-Amyloid Impairment of Endothelial Function
Gentile, M. T., Vecchione, C., Maffei, A., Aretini, A., Marino, G., Poulet, R., Capobianco, L., Selvetella, G., & Lembo, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407358200 · Cited by 92
Chuang, J.-Y., Lee, C.-W., Shih, Y.-H., Yang, T., Yu, L., & Kuo, Y.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033120 · Cited by 95
Implications of Vascular Aging
Barodka, V. M., Joshi, B. L., Berkowitz, D. E., Hogue, C. W. J., & Nyhan, D. P. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182147e3c · Cited by 108
A Review on Blood Pressure and Ischaemic White Matter Lesions
Skoog, I. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051184 · Cited by 92
Bock, M. D., Decrock, E., Wang, N., Bol, M., Vinken, M., Bultynck, G., & Leybaert, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.04.016 · Cited by 97
Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia
Iadecola, C. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025092617651 · Cited by 97
“Aß1–40 is vasoactive also in isolated cerebral vessels, producing a dose-dependent reduction in resting diameter, attenuation of endothelium-dependent responses, and enhancement of responses to vasoconstrictors (Crawford et al., 1998; Niwa et al., 2001; Thomas et al., 1996).”
Vinters, H. V., Natté, R., Maat–Schieman, M. L. C., van Duinen, S. G., Hegeman-Kleinn, I. M., Welling‐Graafland, C., Haan, J., & Roos, R. A. C. (1998) · Acta Neuropathologica · doi:10.1007/s004010050793 · Cited by 94
Statins in the Prevention and Treatment of Alzheimer Disease
Crisby, M., Carlson, L. A., & Winblad, B. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200207000-00001 · Cited by 91
“A is shown to be cytotoxic to neurons, endothelial cells, and oligodendrocytes (Yanker et al., 1989; Thomas et al., 1996; Xu et al., 2001).”
BackgroundFrom Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 98
Blood‐brain barrier damage in vascular dementia
Ueno, M., Chiba, Y., Matsumoto, K., Murakami, R., Fujihara, R., Kawauchi, M., Miyanaka, H., & Nakagawa, T. (2016) · Neuropathology · doi:10.1111/neup.12262 · Cited by 86
“The finding that Aβ is either directly or indirectly responsible for endothelial toxicity is consistent with another paper, in which Aβ is shown to interact with endothelial cells on blood vessels to produce an excess of superoxide radicals, with attendant alterations in endothelial structure and function.(70) Accordi…”
ResultThe Pathophysiology and Clinical Presentation of Cerebral Amyloid Angiopathy
Auriel, E., & Greenberg, S. M. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0254-z · Cited by 95
Modification of Proteins in Endothelial Cell Death during Oxidative Stress
Ciolino, H. P., & Levine, R. L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00495-9 · Cited by 89
Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆
Shi, J., Perry, G. L., Smith, M. A., & Friedland, R. P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00119-6 · Cited by 95
Oxidative Damage in Neurodegenerative Diseases
Beal, M. F. (1997) · The Neuroscientist · doi:10.1177/107385849700300112 · Cited by 89
Blood–brain barrier endothelial cells in neurodegenerative diseases: Signals from the “barrier”
Yuan, Y., Sun, J., Dong, Q., & Cui, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1047778 · Cited by 93
“Barrier-type brain endothelial cell dysfunction is considered to be one of the Aβ-induced pathological changes in AD (Thomas et al., 1996; Vagnucci and Li, 2003).”
BackgroundCerebrovascular disorders: molecular insights and therapeutic opportunities
Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 96
Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation
Nilsson, L. N. G., Arendash, G. W., Leighty, R. E., Costa, D. A., Low, M. A., Garcia, M. F., Cracciolo, J. R., Rojiani, A. M., Wu, X., Bales, K. R., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.011 · Cited by 97
“It is also possible that acute cognitive benefits of passive vaccination derive from the resulting reduction in the vasoconstrictor activity of A [63] or to alleviated hemodynamic responses [42], either of which could enhance cerebral blood flow and improve cognition without providing insight into the mechanism by whi…”
BackgroundPlasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation
Shen, M., Chen, F.-Y., Hsu, J., Fu, R., Chang, C., Chang, C.-T., Liu, C.-H., Wu, J.-R., Lee, A., Chan, H., et al. (2015) · Blood · doi:10.1182/blood-2015-05-646117 · Cited by 87
Volumetric distribution of perivascular space in relation to mild cognitive impairment
Sepehrband, F., Barisano, G., Sheikh‐Bahaei, N., Choupan, J., Cabeen, R. P., Lynch, K. M., Crawford, M. S., Lan, H., Mack, W. J., Chui, H. C., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.010 · Cited by 89
Cerebral Hypoperfusion and the Energy Deficit in A lzheimer's Disease
Love, S., & Miners, J. S. (2016) · Brain Pathology · doi:10.1111/bpa.12401 · Cited by 93
“The vasoconstriction can be reduced by free radical scavengers and cyclo-oxygenase inhibitors (99, 112, 135, 140).”
BackgroundLiu, T., Perry, G., Chan, H. W., Verdile, G., Martins, R. N., Smith, M. A., & Atwood, C. S. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02196.x · Cited by 86
“2002) and subsequent neuronal or vascular endothelial cell death (Behl et al. 1994; Busciglio and Yankner 1995; Hensley et al. 1995; Thomas et al. 1996).”
BackgroundSuperoxide free radical and intracellular calcium mediate Aβ1–42 induced endothelial toxicity
Suo, Z., Fang, C., Crawford, F., & Mullan, M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00383-1 · Cited by 92
Self-citationHölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82
“page 28 [251].”
Wu, Y., Bogale, T. A., Koıstınaho, J., Pizzi, M., Rõlova, T., & Bellucci, A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02696-z · Cited by 91
“Multiple rodent studies have shown that A β , Tau and α -syn pathology can disrupt brain vascular homeostasis either by directly interacting with BBB cell components or by promoting a neuroinflam-matory state, that can severely perturb BBB permeability [11, 33, 34, 37, 77, 132].”
BackgroundCirculating beta amyloid protein is elevated in patients with acute ischemic stroke
Lee, P. H., Bang, O. Y., Hwang, E. M., Lee, J. S., Joo, U. S., Mook-Jung, I., & Huh, K. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0274-0 · Cited by 82
“Ab1–40, the major constituent of cerebrovascular amyloid, has a more vasoactive property, which alters endothelial structure and function of the cerebrovasculature (Thomas et al., 1996), and also exhibits directly cellular toxicity (Zhu et al.”
BackgroundLang, D., Mosfer, S. I., Shakesby, A., Donaldson, F., & Lewis, M. J. (2000) · Circulation Research · doi:10.1161/01.res.86.4.463 · Cited by 82
Association of Plasma Aß Peptides with Blood Pressure in the Elderly
Lambert, J.-C., Dallongeville, J., Ellis, K. A., Schraen-Maschke, S., Lui, J., Laws, S., Dumont, J., Richard, F., Cottel, D., Berr, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018536 · Cited by 78
Soluble adhesion molecules and angiotensin-converting enzyme in dementia
Nielsen, H. M., Londos, E., Minthon, L., & Janciauskiene, S. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.011 · Cited by 80
Re-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 79
“Aβ itself is a potent vasoconstrictor (Thomas et al., 1996), worsening the hypoperfusion, which, if severe enough, directly injures neurons.”
BackgroundSphingosine kinase/sphingosine 1-phosphate signalling in central nervous system
Okada, T., Kajimoto, T., Jahangeer, S. M., & Nakamura, S. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.07.011 · Cited by 86
miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Mushtaq, G., H. Greig, N., Anwar, F., A. Zamzami, M., Choudhry, H., M. Shaik, M., A. Tamargo, I., & A. Kamal, M. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151030112140 · Cited by 78
Stefani, M. (2007) · The Neuroscientist · doi:10.1177/1073858407303428 · Cited by 87
Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature
TOWNSEND, K. P., OBREGON, D., QUADROS, A., PATEL, N., VOLMAR, C., PARIS, D., & MULLAN, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04799.x · Cited by 76
Self-citationDeterminants of platelet activation in Alzheimer's disease
Ciabattoni, G., Porreca, E., Febbo, C. D., Iorio, A. D., Paganelli, R., Bucciarelli, T., Pescara, L., Re, L. D., Giusti, C., Falco, A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.011 · Cited by 80
Alcohol, wine and mental health: focus on dementia and stroke
Pinder, R. M., & Sandler, M. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800402 · Cited by 77
“Alzheimer’s disease is characterized by the deposition of amyloid plaques in the brain, a process which involves oxidative mechanisms, while normal ageing has been ascribed to the generation of free radicals (Mattson and Rydel, 1996; Thomas et al., 1996).”
BackgroundHan, J. H., Lee, Y. S., Im, J. H., Ham, Y. W., Lee, H. P., Han, S. B., & Hong, J. T. (2019) · Marine Drugs · doi:10.3390/md17020123 · Cited by 75
Dementia: Alzheimer pathology and vascular factors: From mutually exclusive to interaction
van Norden, A. G. W., van Dijk, E. J., de Laat, K. F., Scheltens, P., Olde-Rikkert, M. G. M., & de Leeuw, F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.003 · Cited by 88
Suo, Z., Wu, M., Citron, B. A., Wong, G. T., & Festoff, B. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4856-03.2004 · Cited by 75
“Because receptors for both phenylephrine and ET-1 are also GPCRs, it would be interesting to know whether the A -impaired GPCR desensitization by GRKs also underlies the A vasoactivity.”
BackgroundInfluentialIzumihara, A., Ishihara, T., Iwamoto, N., Yamashita, K., & Ito, H. (1999) · Stroke · doi:10.1161/01.str.30.1.29 · Cited by 82
Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients.
Charlton, K. E., Rabinowitz, T. L., Geffen, L., & Dhansay, M. A. (2004) · PubMed · Cited by 84
Emerging Roles of Endothelial Nitric Oxide in Preservation of Cognitive Health
Katusic, Z. S., d’Uscio, L. V., & He, T. (2023) · Stroke · doi:10.1161/strokeaha.122.041444 · Cited by 73
Thermodynamic Selection of Steric Zipper Patterns in the Amyloid Cross-β Spine
Park, J., Kahng, B., & Hwang, W. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000492 · Cited by 73
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease
Etiene, D., Kraft, J., Ganju, N., Gomez-Isla, T., Gemelli, B., Hyman, B. T., Hedley-Whyte, E. T., Wands, J. R., & de la Monte, S. M. (1998) · Journal of Alzheimer’s Disease · doi:10.3233/jad-1998-1205 · Cited by 74
Beyond the Signal Sequence: Protein Routing in Health and Disease
Castro-Fernández, C., Maya‐Núñez, G., & Conn, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0010 · Cited by 76
“In the conformational disorders the impairment of cellular function is usually the result of direct interactions between the aggregated proteins with a particular cellular component (151, 152).”
BackgroundRole of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
Carvalho, C., Correia, S. C., Santos, R. X., Cardoso, S., Moreira, P. I., Clark, T. A., Zhu, X., Smith, M. A., & Perry, G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9247-1 · Cited by 72
“Application of exogenous Aβ to normal blood vessels ex vivo causes endothelium-dependent vasoconstriction with decrease in blood flow and, consequently, oxygen levels (Thomas et al. 1996; Townsend et al. 2002).”
BackgroundLiu, T., Liu, W., Zhao, J., Meng, F., & Wang, H. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9360-y · Cited by 75
“Beta-amyloid-induced cellular stress causes oxidative damage to the relaxing factors in the endothelium (Thomas et al., 1996).”
BackgroundParis, D., Town, T., Parker, T. A., Tan, J., Humphrey, J., Crawford, F., & MULLAN, M. J. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7055 · Cited by 72
Self-citationKavanaugh, B., Beesley, J., Itoh, T., Itoh, A., Grinspan, J. B., & Pleasure, D. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6<725::aid-jnr4>3.0.co;2-v · Cited by 41
Su, G. C., Arendash, G. W., Kalaria, R. N., Bjugstad, K. B., & MULLAN, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01143-3 · Cited by 71
Self-citationCerebral Amyloid Angiopathy: Progressive Disruption of the Neurovascular Unit
Zipfel, G. J., Han, H., Ford, A. L., & Lee, J.-M. (2009) · Stroke · doi:10.1161/strokeaha.108.533174 · Cited by 66
Zinc and Health: Current Status and Future Directions
Hambidge, M. (2000) · Cited by 86
Amyloid-Beta Peptide Is Toxic to Neurons In Vivo via Indirect Mechanisms
Walsh, D. T., Montero, R. M., Bresciani, L. G., Jen, A. Y. T., Leclercq, P. D., Saunders, D., EL-Amir, A. N., Gbadamoshi, L., Gentleman, S. M., & Jen, L.-S. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0485 · Cited by 66
Guerriero, F., & Ricevuti, G. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.195277 · Cited by 76
“…with degenerating endothelium (decreased mitochondrial content, increased pinocytotic vesicles), damaged smooth muscle cells and pericytes, and basement membrane changes (focal necrosis, reduplication, increased collagen content, disintegrating) (Thomas et al., 1996; Wardlaw et al., 2003).”
Niskakangas, T., Öhman, J. E., Niemela, M. R., Ilveskoski, E., Kunnas, T. A., & Karhunen, P. J. (2001) · Stroke · doi:10.1161/01.str.32.5.1181 · Cited by 72
Barkats, M., Millecamps, S., Abrioux, P., Geoffroy, M., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751438.x · Cited by 75
“In addition to its neurotoxic role, Ab has been reported to induce vascular dysfunction, which may be a contributing factor to AD (Thomas et al., 1996).”
Backgroundβ-Amyloid (1–42) peptide impairs blood-brain barrier function after intracarotid infusion in rats
Jancsó, G., Domoki, F., Sántha, P., Varga, J., Fischer, J., Orosz, K., Penke, B., Becskei, A., Dux, M., & Tóth, L. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00622-3 · Cited by 68
Suhara, T., Magrané, J., Rosen, K., Christensen, R., Kim, H.-S., Zheng, B., McPhie, D. L., Walsh, K., & Querfurth, H. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00135-5 · Cited by 70
Neuronal nicotinic acetylcholine receptor–cholesterol crosstalk in Alzheimer's disease
Barrantes, F. J., Borroni, V., & Vallés, S. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.11.036 · Cited by 67
“with more atheromatous plaques [55].”
Neuroprotective Mechanisms Mediated by CDK5 Inhibition
Mushtaq, G., Greig, N. H., Anwar, F., Al-Abbasi, F. A., Zamzami, M. A., Al-Talhi, H. A., & Kamal, M. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151124235028 · Cited by 67
Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
Paris, D., Town, T., Mori, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00111-6 · Cited by 71
“[86] Thomas T, Thomas G, McLendon C, Sutton T, and Mullan M.”
BackgroundSelf-citationPoduslo, J. F., Hultman, K. L., Curran, G. L., Preboske, G. M., Chamberlain, R., Marjańska, M., Garwood, M., Jack, C. R., & Wengenack, T. M. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318225038c · Cited by 64
Human Truncated Tau is Using a Different Mechanism from Amyloid-β to Damage the Blood-Brain Barrier
Kovac, A., Zilkova, M., Deli, M. A., Zilka, N., & Novak, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1197 · Cited by 60
“Strikingly, truncated tau does not exercise a direct cytotoxic effect on brain endothelial cells which is in strong opposition to Aβ that has been shown to be toxic to cultured human brain endothelial cells [33,34,59,60].”
BackgroundAldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
Srivastava, S., Spite, M. R., Trent, J. O., West, M., Ahmed, Y., & Bhatnagar, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403416200 · Cited by 69
(2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.2.m103 · Cited by 64
β-Amyloid-Induced Endothelial Necrosis and Inhibition of Nitric Oxide Production
Sutton, E. T., Hellermann, G., & Thomas, T. (1997) · Experimental Cell Research · doi:10.1006/excr.1996.3440 · Cited by 66
Self-citationPrP and β‐Amyloid Fragments Activate Different Neurotoxic Mechanisms in Cultured Mouse Cells
Brown, D. R., Herms, J. W., Schmidt, B., & Kretzschmar, H. A. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01470.x · Cited by 65
β-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain
Price, J., Sutton, T., Hellermann, A., & Thomas, T. (1997) · Neurological Research · doi:10.1080/01616412.1997.11740853 · Cited by 63
Self-citationActivated endothelial cells induce a distinct type of astrocytic reactivity
Taylor, X., Cisternas, P., Jury, N., Martinez, P., Huang, X., You, Y., Redding-Ochoa, J., Vidal, R., Zhang, J., Troncoso, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03237-8 · Cited by 59
Vascular disorder in Alzheimer’s disease: role in pathogenesis of dementia and therapeutic targets
Zloković, B. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00150-3 · Cited by 73
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases
Hikosaka, K., Yaku, K., Okabe, K., & Nakagawa, T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1637504 · Cited by 62
Association between atherosclerosis and Alzheimer's disease: A systematic review and meta‐analysis
Xie, B.-J., Shi, X.-R., Xing, Y., & Tang, Y. (2020) · Brain and Behavior · doi:10.1002/brb3.1601 · Cited by 53
Milton, N. G. N. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00064-x · Cited by 69
The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
Gordon, B. A., Najmi, S., Hsu, P., Roe, C. M., Morris, J. C., & Benzinger, T. L. S. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.04.017 · Cited by 56
“A β leads to oxidative damage and the formation of free radicals (Hensley et al., 1994; Park et al., 2004; Thomas et al., 1996), and the administration of A β damages oligodendrocytes in vitro (Roth et al., 2005) and in vivo (Jantaratnotai et al., 2003).”
Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly
Scott, J. A., Braskie, M. N., Tosun, D., Thompson, P. M., Weiner, M., DeCarli, C., & Carmichael, O. T. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00221 · Cited by 59
“…confirmed, this finding supports a mechanism in which long-term exposure to elevated BP and other vascular risks weakens the integrity of the cerebral vasculature, leaving it less well equipped to facilitate the clearance of amyloid as its production accelerates later in life (Thomas et al., 1996).”
ResultTian, J., Shi, J., Smallman, R., Iwatsubo, T., & Mann, D. M. A. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00732.x · Cited by 61
Vascular pathology and pathogenesis of cognitive impairment and dementia in older adults
Agrawal, S., & Schneider, J. A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100148 · Cited by 76
“Vascular Aβ deposition can lead to vascular degeneration, in particular endothelial cell disruption [66], pericytes degeneration [67], and disruption of smooth muscle [68], leading to decreased vascular compliance and elasticity.”
BackgroundPurification of a Vascular Apoptosis-Inducing Factor from Hemorrhagic Snake Venom
Masuda, S., Araki, S., Yamamoto, T., Kaji, K., & Hayashi, H. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6728 · Cited by 61
CD40 signaling and Alzheimer's disease pathogenesis
Town, T., Tan, J., & MULLAN, M. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00044-4 · Cited by 65
Self-citationEmerging biophysical origins and pathogenic implications of amyloid oligomers
Tang, H., Andrikopoulos, N., Li, Y., Ke, S., Sun, Y., Ding, F., & Ke, P. C. (2025) · Nature Communications · doi:10.1038/s41467-025-58335-y · Cited by 72
Nanosignal Processing: Stochastic Resonance in Carbon Nanotubes That Detect Subthreshold Signals
Lee, I. Y., Liu, X., Kosko, B., & Zhou, C. (2003) · Nano Letters · doi:10.1021/nl0348239 · Cited by 60
Strazielle, N., Ghersi-Egea, J.-F., Ghiso, J., Dehouck, M.-P., Frangione, B., Patlak, C., Fenstermacher, J., & Gorevic, P. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.29 · Cited by 59
Red wine micronutrients as protective agents in Alzheimer-like induced insult
Russo, A., Palumbo, M., Aliano, C., Lempereur, L., Scoto, G. M., & Renis, M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00123-1 · Cited by 66
tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β
Park, L., Zhou, J., Koizumi, K., Wang, G., Anfray, A., Ahn, S. J., Seo, J., Zhou, P., Zhao, L., Paul, S. M., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1140-20.2020 · Cited by 60
“Ab impairs endothelium-dependent relaxation (Thomas et al., 1996), reduces resting CBF (Niwa et al., 2002a), dampens neurovascular coupling (Niwa et al., 2000c; Tong et al., 2012; Nortley et al., 2019), and alters the ability of cerebral blood vessels to regulate CBF independently of arterial…”
BackgroundCerebral hemodynamics of the aging brain: risk of Alzheimer disease and benefit of aerobic exercise
Tarumi, T., & Zhang, R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00006 · Cited by 70
“Consistently, exposure of cerebrovascular endothelium to amyloid-β (Aβ) peptide acutely impairs endothelium-dependent vasodilation by augmenting oxidative stress (Thomas et al., 1996).”
Background
Metadata
- Authors
- Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M.
- Affiliations
- University of South Florida (US)
- Venue
- Nature
- Published
- 1996-03
- Volume
- 380
- Issue
- 6570
- Pages
- 168-171
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1990427131
- Cited by
- 703
- References
- 12
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 18 · 2023: 22 · 2022: 9 · 2021: 15 · 2020: 24 · 2019: 19 · 2018: 5 · 2017: 12 · 2016: 22 · 2015: 26 · 2014: 16 · 2013: 26 · 2012: 13
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- amyloid-beta, Alzheimer's disease, vascular endothelial cells, superoxide, free radicals, superoxide dismutase, endothelium-derived relaxing factor, lipid peroxidation, vascular tone, neurodegeneration, aging, oxidative stress
- MeSH terms
- Acetylcholine, Alzheimer Disease, Animals, Aorta, Blood Vessels, Endothelium, Vascular, Nerve Degeneration, Phenylephrine, Superoxides, Vasoconstriction, Vasoconstrictor Agents, Vasodilator Agents, Amyloid beta-Peptides, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.